Teva Pharmaceuticals Sees Pivot to Growth Accelerating on Branded Drugs, Biosimilars

Summary

Teva Pharmaceuticals is shifting its business strategy to focus on growth through branded drugs and biosimilars. The article indicates an acceleration of this strategic pivot but lacks specific financial or clinical details.